Alpha Cognition Inc. (ACOG) Stock Price, Financials & Summary

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18

Key dataSep 18, 2026

Open$8.94

From 52W high−9.44%

Volume61875.00

Market cap$192.30M

P/E (TTM)—

P/S (TTM)12.6x

Div yield—

Key dataSep 18, 2026

Open

$8.94

From 52W high

−9.44%

Volume

61875.00

Market cap

$192.30M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−5.5x

P/E (TTM)

—

RSI (14)

48.7

MomentumView details →

1D Return

−0.23%

YTD Return

+36.53%

SummaryUpdated Jun 1, 2026

Alpha Cognition Inc. (NASDAQ:ACOG) is a clinical-stage biopharmaceutical company founded in 2000 and headquartered in Vancouver, Canada. The company was formerly known as Crystal Bridge Enterprises Inc. before changing its name in March 2021. Alpha Cognition focuses on developing treatments for neurodegenerative diseases, particularly Alzheimer's disease and amyotrophic lateral sclerosis (ALS). The company successfully transitioned from a pre-revenue clinical-stage entity to a commercial-stage company in 2025 with the launch of its flagship product ZUNVEYL for treating mild-to-moderate Alzheimer's disease.

Ask drillr about Alpha Cognition Inc. →

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−5.5x

EV/Sales

9.9x

P/S (TTM)

12.6x

P/B (TTM)

3.6x

ProfitabilityView details →

Gross Margin

89.89%

Net Margin

−153.61%

EBITDA Margin

−180.73%

ROE (TTM)

−44.26%

ROA (TTM)

−36.33%

Asset Turnover

0.23x

GrowthView details →

Revenue YoY

+232.74%

EPS YoY

+31.77%

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

+42.08%

EBITDA YoY

−83.08%

MomentumView details →

1D Return

−0.23%

YTD Return

+36.53%

1Y Return

+10.66%

RSI (14)

48.7

vs 50D SMA

+0.65%

vs 200D SMA

+31.69%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

9.03x

Quick Ratio

8.04x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.40

EPS Surprise

−2.00%

Beats (12Q)

4/12

Next Q EPS Est

−$0.34

Avg Surprise (4Q)

6.72%

Rev Surprise

36.86%

Financials snapshotView financials →

Revenue (TTM)

15.26M

Net Income (TTM)

−23.44M

Op. CF (TTM)

−30.91M

Next earningsNov 12, 2026 →

Latest newsMore news →

Alpha Cognition Inc. granted inducement stock options to purchase 25,000 shares of common stock to a new non-executive employee on September 8, 2026, under its 2026 Inducement Grant Plan.11d ago

Similar companies

Apogee Acquisition Corp UnitsAACPU FACT II Acquisition Corp. UnitFACTU Newbury Street II Acquisition CorpNTWOU Breeze Acquisition Corp. IIBREZ Ampercap Acquisition Co.APMC A Paradise Acquisition Corp.ENHA Find similar companies →

Latest newsMore news →

Saudi Minister Abdullah Alswaha met with Cognition AI Co-Founder and CEO Scott Wu to discuss expanding use of autonomous software engineering solutions and deploying Devin and software agents through HUMAIN's computing capabilities.10d ago Alpha Cognition Inc. granted inducement stock options to purchase 25,000 shares of common stock to a new non-executive employee on September 8, 2026, under its 2026 Inducement Grant Plan.11d ago